Evaluation of the novel protein kinase C inhibitor sotrastaurin as immunosuppressive therapy after renal transplantation-Reference-Cited by-同舟云学术

Evaluation of the novel protein kinase C inhibitor sotrastaurin as immunosuppressive therapy after renal transplantation

Published:2010-12-08 Issue:1 Volume:7 Page:103-113
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Matz Mareen,Naik Marcel,Mashreghi Mir-Farzin,Glander Petra,Neumayer Hans-H,Budde Klemens

Publisher

Informa Healthcare

Subject

Pharmacology,Toxicology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/17425255.2011.540238

Reference80 articles.

1. U S Renal Data System UADRAoCKDaE-SRDitUS, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD; 2009

2. BK-virus nephropathy in renal transplants—tubular necrosis, MHC-class II expression and rejection in a puzzling game

3. Immunosuppressive Drugs in Kidney Transplantation

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ANTITUMOR DRUGS BASED ON INDOLOCARBAZOL DERIVATIVES;Pharmacy & Pharmacology;2021-09-08

2. Transplantation and immunosuppression: a review of novel transplant-related immunosuppressant drugs;Immunopharmacology and Immunotoxicology;2021-08-20

3. Emerging Pathophysiological Targets of Psoriasis for Future Therapeutic Strategies;Infectious Disorders - Drug Targets;2020-10-16

4. Discovery of 2,4-diamino-5-cyanopyrimidine derivatives as protein kinase C theta inhibitors with mitigated time-dependent drug-drug interactions;Bioorganic & Medicinal Chemistry;2019-03

5. A novel 2,4-diaminopyrimidine derivative as selective inhibitor of protein kinase C theta prevents allograft rejection in a rat heart transplant model;Bioorganic & Medicinal Chemistry;2018-11